Phospho-SAMHD1 (Thr592) Antibody - #AF3508
製品説明
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
引用形式: Affinity Biosciences Cat# AF3508, RRID:AB_2846822.
折りたたみ/展開
CHBL2; DCIP; Dendritic cell derived IFNG induced protein; Dendritic cell-derived IFNG-induced protein; Deoxynucleoside triphosphate triphosphohydrolase SAMHD1; dNTPase; HD domain containing 1; HDDC1; Mg11; Monocyte protein 5; MOP 5; MOP-5; MOP5; OTTHUMP00000030889; SAM domain and HD domain 1; SAM domain and HD domain containing protein 1; SAM domain and HD domain-containing protein 1; SAMH1_HUMAN; Samhd1; SBBI88;
免疫原
A synthesized peptide derived from human SAMHD1 around the phosphorylation site of Thr592.
Expressed in heart, skeletal muscle, spleen, liver, small intestine, placenta, lung and peripheral blood leukocytes (PubMed:11064105). No expression is seen in brain and thymus (PubMed:11064105).
- Q9Y3Z3 SAMH1_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MQRADSEQPSKRPRCDDSPRTPSNTPSAEADWSPGLELHPDYKTWGPEQVCSFLRRGGFEEPVLLKNIRENEITGALLPCLDESRFENLGVSSLGERKKLLSYIQRLVQIHVDTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCHDLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM
PTMs - Q9Y3Z3 基板として
Site | PTM Type | Enzyme | Source |
---|---|---|---|
M1 | Acetylation | Uniprot | |
S6 | Phosphorylation | Uniprot | |
K11 | Ubiquitination | Uniprot | |
S18 | Phosphorylation | Uniprot | |
T21 | Phosphorylation | Uniprot | |
S23 | Phosphorylation | Uniprot | |
T25 | Phosphorylation | Uniprot | |
S27 | Phosphorylation | Uniprot | |
S33 | Phosphorylation | Uniprot | |
K66 | Ubiquitination | Uniprot | |
S93 | Phosphorylation | Uniprot | |
K98 | Ubiquitination | Uniprot | |
K99 | Ubiquitination | Uniprot | |
S102 | Phosphorylation | Uniprot | |
Y103 | Phosphorylation | Uniprot | |
T138 | Phosphorylation | Uniprot | |
Y146 | Phosphorylation | Uniprot | |
K148 | Ubiquitination | Uniprot | |
Y155 | Phosphorylation | Uniprot | |
S278 | Phosphorylation | Uniprot | |
K288 | Ubiquitination | Uniprot | |
K294 | Acetylation | Uniprot | |
K294 | Ubiquitination | Uniprot | |
K304 | Ubiquitination | Uniprot | |
K312 | Ubiquitination | Uniprot | |
Y315 | Phosphorylation | Uniprot | |
K332 | Sumoylation | Uniprot | |
T384 | Phosphorylation | Uniprot | |
T387 | Phosphorylation | Uniprot | |
K405 | Ubiquitination | Uniprot | |
Y419 | Phosphorylation | Uniprot | |
Y432 | Phosphorylation | Uniprot | |
K446 | Ubiquitination | Uniprot | |
K455 | Ubiquitination | Uniprot | |
K467 | Ubiquitination | Uniprot | |
K469 | Sumoylation | Uniprot | |
K478 | Ubiquitination | Uniprot | |
S482 | Phosphorylation | Uniprot | |
K486 | Ubiquitination | Uniprot | |
Y507 | Phosphorylation | Uniprot | |
S519 | Phosphorylation | Uniprot | |
K534 | Ubiquitination | Uniprot | |
K544 | Ubiquitination | Uniprot | |
Y553 | Phosphorylation | Uniprot | |
K560 | Ubiquitination | Uniprot | |
T579 | Phosphorylation | Uniprot | |
T592 | Phosphorylation | P24941 (CDK2) , P06493 (CDK1) | Uniprot |
K595 | Sumoylation | Uniprot | |
K596 | Ubiquitination | Uniprot | |
S601 | Phosphorylation | Uniprot | |
T608 | Phosphorylation | Uniprot | |
S616 | Phosphorylation | Uniprot | |
K622 | Sumoylation | Uniprot |
研究背景
Protein that acts both as a host restriction factor involved in defense response to virus and as a regulator of DNA end resection at stalled replication forks. Has deoxynucleoside triphosphate (dNTPase) activity, which is required to restrict infection by viruses, such as HIV-1: dNTPase activity reduces cellular dNTP levels to levels too low for retroviral reverse transcription to occur, blocking early-stage virus replication in dendritic and other myeloid cells. Likewise, suppresses LINE-1 retrotransposon activity. Not able to restrict infection by HIV-2 virus; because restriction activity is counteracted by HIV-2 viral protein Vpx. In addition to virus restriction, dNTPase activity acts as a regulator of DNA precursor pools by regulating dNTP pools. Phosphorylation at Thr-592 acts as a switch to control dNTPase-dependent and -independent functions: it inhibits dNTPase activity and ability to restrict infection by viruses, while it promotes DNA end resection at stalled replication forks. Functions during S phase at stalled DNA replication forks to promote the resection of gapped or reversed forks: acts by stimulating the exonuclease activity of MRE11, activating the ATR-CHK1 pathway and allowing the forks to restart replication. Its ability to promote degradation of nascent DNA at stalled replication forks is required to prevent induction of type I interferons, thereby preventing chronic inflammation. Ability to promote DNA end resection at stalled replication forks is independent of dNTPase activity. Enhances immunoglobulin hypermutation in B-lymphocytes by promoting transversion mutation (By similarity).
Phosphorylation at Thr-592 by CDK1 acts as a switch to control deoxynucleoside triphosphate (dNTPase)-dependent and -independent functions. Phosphorylation at Thr-592 takes place in cycling cells: it reduces the stability of the homotetramer, impairing the dNTPase activity and subsequent ability to restrict infection by viruses. It also inhibits ability to suppress LINE-1 retrotransposon activity. In contrast, phosphorylation at Thr-592 promotes DNA end resection at stalled replication forks in response to DNA damage.
(Microbial infection) Ubiquitinated following interaction with HIV-2 viral protein Vpx; Vpx promotes interaction and with a DCX (DDB1-CUL4-X-box) E3 ubiquitin ligase, leading to proteasomal degradation.
Nucleus. Chromosome.
Note: Localizes to sites of DNA double-strand breaks in response to DNA damage.
Expressed in heart, skeletal muscle, spleen, liver, small intestine, placenta, lung and peripheral blood leukocytes. No expression is seen in brain and thymus.
Homodimer; in absence of GTP and dNTP. Homotetramer; in GTP- and dNTP-bound form. Interacts with MRE11; leading to stimulate the exonuclease activity of MRE11. Interacts with RBBP8/CtIP. Interacts (via its C-terminus) with CD81.
(Microbial infection) Interacts with HIV-2 viral protein Vpx; promoting interaction with a E3 ubiquitin-protein ligase complex containing DCAF1, leading to subsequent ubiquitination and degradation of SAMHD1.
In human, and in contrast to mouse protein, the SAM domain is not required for deoxynucleoside triphosphate (dNTPase) activity and ability to restrict infection by viruses.
Belongs to the SAMHD1 family.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.